{"id":957832,"date":"2026-05-04T16:38:47","date_gmt":"2026-05-04T20:38:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/"},"modified":"2026-05-04T16:38:47","modified_gmt":"2026-05-04T20:38:47","slug":"eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/","title":{"rendered":"Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>DEER PARK, Ill., May  04, 2026  (GLOBE NEWSWIRE) &#8212; Eton Pharmaceuticals, Inc (\u201cEton\u201d or the \u201cCompany\u201d) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report first quarter 2026 financial results on Thursday, May 14, 2026. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET (3:30 p.m. CT).<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:20%;width:20%;min-width:20%\">Participant Call Link:<\/td>\n<td style=\"max-width:80%;width:80%;min-width:80%\">\n            <a href=\"https:\/\/register-conf.media-server.com\/register\/BI03b2881417de40f1939213b2fe060bc9\" rel=\"nofollow\" target=\"_blank\">Click Here<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td>Webcast:<\/td>\n<td>\n            <a href=\"https:\/\/edge.media-server.com\/mmc\/p\/w3ob9qff\" rel=\"nofollow\" target=\"_blank\">Click Here<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<\/table>\n<p> \u00a0In addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors. Investors can email questions to: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZpOEEUaCJ0Bg4CPwm6lwz9nBXNL04Z6v3tu_lZc-x7wIX5j2uMMfYZazeRYSWf2G50kCEG61OGufJkt2RI4ZGOrF5IKh35dsdbOFuzwSTCc_LVeViwRZYJlzKCWvfunwD0I83hcqaAvWq5_NI08iig==\" rel=\"nofollow\" target=\"_blank\">investorrelations@etonpharma.com<\/a>.<\/p>\n<p>The live webcast can also be accessed on the Investors section of Eton\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=C3GAbCkr8vPmo5BX9Y_LwWllHGrtWMxrfgMUXTC3UavBft7fcRWbMW_xStf3Wk0ifrRNa_dPlsCGYI9A25Su9zDP-mt4kwnEnKMm8dGi7to=\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.etonpharma.com\/<\/a>. An archived webcast will be available on Eton\u2019s website approximately two hours after the completion of the event and for 30 days thereafter.<\/p>\n<p>\n        <strong>About Eton Pharmaceuticals<\/strong>\n      <\/p>\n<p>Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has ten commercial rare disease products: KHINDIVI<sup>TM<\/sup>, INCRELEX<sup>\u00ae<\/sup>, ALKINDI SPRINKLE<sup>\u00ae<\/sup>, DESMODA\u2122, GALZIN<sup>\u00ae<\/sup>, HEMANGEOL<sup>\u00ae<\/sup>, PKU GOLIKE<sup>\u00ae<\/sup>, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has four additional product candidates in late-stage development: Amglidia<sup>\u00ae<\/sup>, ET-700, ET-800 and ZENEO<sup>\u00ae<\/sup> hydrocortisone autoinjector. For more information, please visit our website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ja9NllTm1fFK9AKg4DFN-Ew43ktDHMjgJ3czXxV7uBdf0LZqqN4MkE1NTiVxhsynOSD-7P_LFllVESG59Kb15U7VAMqqLuVspLRAwKsBba2XqA3sdHWdAbrppQWYrhAIEVx_bS0jE05-JGneuZJdKgTdF76U9WJ8N9-Tf6BL4KYv9AZmc_uPwHgJ5V7b1gDTjgqDxnU-B1SjYH9GK9iRaTulNq-piwUOZqDg3fWQ0XzvwffruyIuZzJXdyO4OuyxF6MHeJ1dPsOKpPm8cEaB5Q==\" rel=\"nofollow\" target=\"_blank\">www.etonpharma.com<\/a>.<\/p>\n<p>\n        <strong>Investor Relations:<\/strong>\n      <\/p>\n<p>Lisa M. Wilson<br \/>In-Site Communications, Inc.<br \/>T: 212-452-2793<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rYBtVT4C9DYiwl6MsYfiPo18nWCrZfC942Vur7EUj9j9SrtIDh0rV62Q9fHToZHgzRqVqRJ5VlODMHiX-NRk14cwsd1wT4UqvsoXW2jLcQ7SSi13IzS9uF2aawV-PRpzUKNZoYki5xUXrT6uhfoY2k6Ee_iSpjVpwnlTrTp6ncSn0KKqo7rB2H2WWGxICNIePaEBtLmd1bnv9ZFH67_xl813dzLzyOkMBpzh2Q2DkcyBmNHJYUhIjhLlm8XP0Y-JiDVsByKoof-uVYqCFNY6_A==\" rel=\"nofollow\" target=\"_blank\">lwilson@insitecony.com<\/a><\/p>\n<p>Source: Eton Pharmaceuticals, Inc.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjU5NCM3NTgxNjY3IzIxMjI5ODQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ODQ5ZDI2OTctZDE4ZC00ZDNjLTk0YWUtMjkwZGNlOGUyMDdkLTExMzQ1NTUtMjAyNi0wNS0wNC1lbg==\/tiny\/Eton-Pharmaceuticals.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>DEER PARK, Ill., May 04, 2026 (GLOBE NEWSWIRE) &#8212; Eton Pharmaceuticals, Inc (\u201cEton\u201d or the \u201cCompany\u201d) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report first quarter 2026 financial results on Thursday, May 14, 2026. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET (3:30 p.m. CT). Participant Call Link: Click Here \u00a0 \u00a0 Webcast: Click Here \u00a0 \u00a0 \u00a0In addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors. Investors can email questions to: investorrelations@etonpharma.com. The live webcast can also be accessed on the Investors section of Eton\u2019s website &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-957832","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DEER PARK, Ill., May 04, 2026 (GLOBE NEWSWIRE) &#8212; Eton Pharmaceuticals, Inc (\u201cEton\u201d or the \u201cCompany\u201d) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report first quarter 2026 financial results on Thursday, May 14, 2026. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET (3:30 p.m. CT). Participant Call Link: Click Here \u00a0 \u00a0 Webcast: Click Here \u00a0 \u00a0 \u00a0In addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors. Investors can email questions to: investorrelations@etonpharma.com. The live webcast can also be accessed on the Investors section of Eton\u2019s website &hellip; Continue reading &quot;Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-04T20:38:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjU5NCM3NTgxNjY3IzIxMjI5ODQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026\",\"datePublished\":\"2026-05-04T20:38:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\\\/\"},\"wordCount\":241,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjU5NCM3NTgxNjY3IzIxMjI5ODQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\\\/\",\"name\":\"Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjU5NCM3NTgxNjY3IzIxMjI5ODQ=\",\"datePublished\":\"2026-05-04T20:38:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjU5NCM3NTgxNjY3IzIxMjI5ODQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjU5NCM3NTgxNjY3IzIxMjI5ODQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/","og_locale":"en_US","og_type":"article","og_title":"Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 - Market Newsdesk","og_description":"DEER PARK, Ill., May 04, 2026 (GLOBE NEWSWIRE) &#8212; Eton Pharmaceuticals, Inc (\u201cEton\u201d or the \u201cCompany\u201d) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report first quarter 2026 financial results on Thursday, May 14, 2026. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET (3:30 p.m. CT). Participant Call Link: Click Here \u00a0 \u00a0 Webcast: Click Here \u00a0 \u00a0 \u00a0In addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors. Investors can email questions to: investorrelations@etonpharma.com. The live webcast can also be accessed on the Investors section of Eton\u2019s website &hellip; Continue reading \"Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-04T20:38:47+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjU5NCM3NTgxNjY3IzIxMjI5ODQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026","datePublished":"2026-05-04T20:38:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/"},"wordCount":241,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjU5NCM3NTgxNjY3IzIxMjI5ODQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/","name":"Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjU5NCM3NTgxNjY3IzIxMjI5ODQ=","datePublished":"2026-05-04T20:38:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjU5NCM3NTgxNjY3IzIxMjI5ODQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjU5NCM3NTgxNjY3IzIxMjI5ODQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/957832","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=957832"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/957832\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=957832"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=957832"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=957832"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}